×
About 18,400 results

ALLMedicine™ Neutropenia Center

Research & Reviews  8,579 results

Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult p...
https://doi.org/10.1080/16078454.2021.1872957
Hematology (Amsterdam, Netherlands); Lee MW, Yeon SH et. al.

Jan 18th, 2021 - Changes in fecal microbiota affect the incidence and extent of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Most patients with hematological malignancies receive antibiotics for the treatment of...

Amoxicillin/clavulanic acid-associated severe neutropenia.
https://doi.org/10.1136/postgradmedj-2020-139415
Postgraduate Medical Journal; Schattner A, Dubin I

Jan 14th, 2021 - Amoxicillin/clavulanic acid-associated severe neutropenia.|2021|Schattner A,Dubin I,|

Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for...
https://doi.org/10.1038/s41409-020-01179-5 10.1038/sj.bmt.1700677 10.1038/sj.bmt.1701888 10.1038/sj.bmt.1702011 10.1038/bmt.2016.228 10.1097/MD.0000000000005396 10.1182/blood-2012-07-445965 10.1016/j.bbmt.2013.11.014 10.1111/j.1365-2141.2012.09070.x 10.1016/j.bbmt.2017.12.782 10.1111/j.1365-2141.2004.05138.x 10.1016/j.bbmt.2008.07.006 10.1182/bloodadvances.2018026963 10.1016/j.bbmt.2019.11.014 10.1016/j.bbmt.2019.07.022 10.1016/j.beha.2006.09.008 10.1111/petr.12455 10.5045/br.2017.52.2.119 10.1016/j.bbmt.2016.12.243 10.1016/j.jaci.2020.04.053 10.1097/TP.0b013e3181e7e54f 10.1016/j.smim.2010.04.012 10.1084/jem.20111675 10.1189/jlb.1209772 10.1016/S0092-8674(04)00335-6 10.1182/blood-2007-12-128488 10.1182/blood-2009-02-206359 10.1007/s10545-013-9613-3 10.1242/jcs.01288 10.1016/j.imlet.2017.07.004 10.3389/fped.2019.00171 10.1182/blood-2011-05-347708 10.1038/sj.bmt.1702774 10.1016/j.bbmt.2014.06.032 10.1002/pbc.25172 10.1182/bloodadvances.2016001412 10.1182/blood-2015-07-657981 10.1111/petr.12172 10.3109/10428191003682767 10.1002/pbc.25122 10.1111/bjh.16171 10.1002/pbc.28010 10.1182/bloodadvances.2018020883 10.1186/s12967-017-1317-2 10.1016/j.cca.2014.09.018 10.1002/pbc.26904 10.1111/ejh.13343 10.3324/haematol.2019.243543 10.1681/ASN.2017060679
Bone Marrow Transplantation; Gupta AO, Jan Boelens J et. al.

Jan 14th, 2021 - Hematopoietic stem cell transplantation (HCT) has been increasingly used for patients with inherited metabolic disorders (IMD). Immune mediated cytopenias (IMCs) after HCT, manifesting as hemolytic anemia, thrombocytopenia, and/or neutropenia, are...

Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast...
https://doi.org/10.1016/j.ejca.2020.12.007
European Journal of Cancer (Oxford, England : 1990); Furlanetto J, Möbus V et. al.

Jan 10th, 2021 - BRCA1 and BRCA2 play a central role in DNA repair. Therefore, patients harbouring germline (g) BRCA1/2 mutations (m) treated with chemotherapy might be at higher risk of haematological toxicities. Patients from German Breast Group (GBG) and Arbeit...

Pooled-analysis of Lipegfilgrastim Effectiveness and Safety Among Patients With Blood M...
https://doi.org/10.21873/anticanres.14782
Anticancer Research; Pettengell R, Wolff T et. al.

Jan 9th, 2021 - The aim of this report was to summarize the real-world experience with lipegfilgrastim as a neutropenia prophylaxis in a large cohort of lymphoma patients receiving immuno-, chemo-therapy. Observational clinical data were derived from two phase IV...

see more →

Guidelines  55 results

Emerging challenges in the evaluation of fever in cancer patients at risk of febrile ne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682766
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Font C et. al.

Nov 24th, 2020 - Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 ...

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by t...
https://www.idsociety.org/globalassets/idsa/practice-guidelines/2019-asymptomatic-bacteriuria.pdf

Mar 20th, 2019 - Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be s.

ACR Appropriateness Criteria® Acute Nonlocalized Abdominal Pain.
https://doi.org/10.1016/j.jacr.2018.09.010
Journal of the American College of Radiology : JACR; , Scheirey CD et. al.

Nov 5th, 2018 - The range of pathology in adults that can produce abdominal pain is broad and necessitates an imaging approach to evaluate many different organ systems. Although localizing pain prompts directed imaging/management, clinical presentations may vary ...

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
http://ascopubs.org/doi/full/10.1200/JCO.18.00374
Taplitz,R.,et al

Sep 3rd, 2018 - Antibacterial and antifungal prophylaxis is recommended for patients who are at high risk of infection, including patients who are expected to have profound, protracted neutropenia, which is defined as < 100 neutrophils/µL for > 7 days or other ri...

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
http://ascopubs.org/doi/full/10.1200/JCO.2017.77.6211
Randy A. Taplitz

May 9th, 2018 - To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA) guideline on outpatient management of fever and neutropenia in patients with cancer.

see more →

Drugs  235 results see all →

Clinicaltrials.gov  9,105 results

Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult p...
https://doi.org/10.1080/16078454.2021.1872957
Hematology (Amsterdam, Netherlands); Lee MW, Yeon SH et. al.

Jan 18th, 2021 - Changes in fecal microbiota affect the incidence and extent of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Most patients with hematological malignancies receive antibiotics for the treatment of...

Amoxicillin/clavulanic acid-associated severe neutropenia.
https://doi.org/10.1136/postgradmedj-2020-139415
Postgraduate Medical Journal; Schattner A, Dubin I

Jan 14th, 2021 - Amoxicillin/clavulanic acid-associated severe neutropenia.|2021|Schattner A,Dubin I,|

Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for...
https://doi.org/10.1038/s41409-020-01179-5 10.1038/sj.bmt.1700677 10.1038/sj.bmt.1701888 10.1038/sj.bmt.1702011 10.1038/bmt.2016.228 10.1097/MD.0000000000005396 10.1182/blood-2012-07-445965 10.1016/j.bbmt.2013.11.014 10.1111/j.1365-2141.2012.09070.x 10.1016/j.bbmt.2017.12.782 10.1111/j.1365-2141.2004.05138.x 10.1016/j.bbmt.2008.07.006 10.1182/bloodadvances.2018026963 10.1016/j.bbmt.2019.11.014 10.1016/j.bbmt.2019.07.022 10.1016/j.beha.2006.09.008 10.1111/petr.12455 10.5045/br.2017.52.2.119 10.1016/j.bbmt.2016.12.243 10.1016/j.jaci.2020.04.053 10.1097/TP.0b013e3181e7e54f 10.1016/j.smim.2010.04.012 10.1084/jem.20111675 10.1189/jlb.1209772 10.1016/S0092-8674(04)00335-6 10.1182/blood-2007-12-128488 10.1182/blood-2009-02-206359 10.1007/s10545-013-9613-3 10.1242/jcs.01288 10.1016/j.imlet.2017.07.004 10.3389/fped.2019.00171 10.1182/blood-2011-05-347708 10.1038/sj.bmt.1702774 10.1016/j.bbmt.2014.06.032 10.1002/pbc.25172 10.1182/bloodadvances.2016001412 10.1182/blood-2015-07-657981 10.1111/petr.12172 10.3109/10428191003682767 10.1002/pbc.25122 10.1111/bjh.16171 10.1002/pbc.28010 10.1182/bloodadvances.2018020883 10.1186/s12967-017-1317-2 10.1016/j.cca.2014.09.018 10.1002/pbc.26904 10.1111/ejh.13343 10.3324/haematol.2019.243543 10.1681/ASN.2017060679
Bone Marrow Transplantation; Gupta AO, Jan Boelens J et. al.

Jan 14th, 2021 - Hematopoietic stem cell transplantation (HCT) has been increasingly used for patients with inherited metabolic disorders (IMD). Immune mediated cytopenias (IMCs) after HCT, manifesting as hemolytic anemia, thrombocytopenia, and/or neutropenia, are...

Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast...
https://doi.org/10.1016/j.ejca.2020.12.007
European Journal of Cancer (Oxford, England : 1990); Furlanetto J, Möbus V et. al.

Jan 10th, 2021 - BRCA1 and BRCA2 play a central role in DNA repair. Therefore, patients harbouring germline (g) BRCA1/2 mutations (m) treated with chemotherapy might be at higher risk of haematological toxicities. Patients from German Breast Group (GBG) and Arbeit...

Pooled-analysis of Lipegfilgrastim Effectiveness and Safety Among Patients With Blood M...
https://doi.org/10.21873/anticanres.14782
Anticancer Research; Pettengell R, Wolff T et. al.

Jan 9th, 2021 - The aim of this report was to summarize the real-world experience with lipegfilgrastim as a neutropenia prophylaxis in a large cohort of lymphoma patients receiving immuno-, chemo-therapy. Observational clinical data were derived from two phase IV...

see more →

News  425 results

Late-Onset Neutropenia More Common Than Expected in Patients on Rituximab
https://www.medscape.com/viewarticle/937807

Sep 21st, 2020 - A new study has found that late-onset neutropenia is a notably common and occasionally serious occurrence in rituximab-treated patients with autoimmune diseases. Dr. Reza Zonozi "The literature on late-onset neutropenia – or LON – has, to date, be...

Skin Lesions and Neutropenic Fever in a 69-Year-Old Woman
https://reference.medscape.com/viewarticle/932875

Jun 25th, 2020 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Fast Five Quiz: Chronic Lymphocytic Leukemia (CLL) Treatment
https://reference.medscape.com/viewarticle/922179

Jun 22nd, 2020 - Many different treatments are available for the management of chronic lymphocytic leukemia (CLL), including a variety of chemotherapy regimens that are frequently used in combination. But chemotherapy can cause neutropenia, the duration of which c...

G-CSF Cuts Febrile Neutropenia Rates in Early Breast Cancer
https://www.medscape.com/viewarticle/932012

Jun 8th, 2020 - Women with early-stage breast cancer had a significantly lower rate of febrile neutropenia when given granulocyte-colony stimulating factors (G-CSF) alongside their chemotherapy rather than the antibiotic ciprofloxacin, indicate new data from a ra...

FDA grants accelerated approval for Immunomedics' breast cancer therapy
https://www.reuters.com/article/us-immunomedics-fda/fda-grants-accelerated-approval-for-immunomedics-breast-cancer-therapy-idUSKCN2242NT

Apr 22nd, 2020 - (Reuters) - Immunomedics Inc won an accelerated approval from the U.S. Food and Drug Administration for Trodelvy, its therapy for a form of invasive breast cancer that has worsened despite two prior rounds of treatment, the company said on Wednesd...

see more →

Patient Education  1 results see all →